Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

<strong>Background</strong> The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. <strong>Methods...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Gaziano, J, Brotons, C, Coppolecchia, R, Cricelli, C, Darius, H, Gorelick, P, Howard, G, Pearson, T, Rothwell, P, Ruilope, L, Tendera, M, Tognoni, G, Committee, A
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: Elsevier 2018

Benzer Materyaller

Benzer Materyaller